Next-Generation Psychedelic Drug Development
ACS Chemical Neuroscience September 15, 2026 Lindsay P. Cameron, Matthew W. Johnson, Kevin S. Murnane et al.
Psychedelic medicine has gained rapid popularity for the treatment of a variety of neuropsychiatric disorders, including depression, anxiety, and post-traumatic stress disorder. As novel psychedelic analogues and treatment regimes emerge, increasing numbers of variables are being tested. Here, we review various approaches and considerations for novel psychedelic therapies, including the...